Nuwellis Announces Closing of $11.04 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq:NUWE) (“Nuwellis” or the “Company”), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the closing of an underwritten public offering of units with gross proceeds of approximately $11.04 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by Nuwellis.
Related news for (NUWE)
- Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
- 24/7 Market News Snapshot 30 September, 2025 – Nuwellis, Inc. Common Stock (NASDAQ:NUWE)
- Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
- 24/7 Market News Snapshot 09 September, 2025 – Nuwellis, Inc. Common Stock (NASDAQ:NUWE)
- MoBot’s Stock Market Highlights – 08/18/25 02:00 PM
